The non-opioid pain, dining and medication (FDA) received approval for adults made by vertex medicines.

The company's “first grade” Suzetrigine pain pills According to the Federal Agency, the green light was taken to treat a moderate pain in adults on Thursday.

According to the drug “pain signal system, in pain signals, in sodium channels, before reaching the brain of pain signals, the pain of pain alarm,” Fda.

Vertex medications' logo in a smartphone. (Pavlo Gonchar / Sopa Pictures / Lightrockets No pictures / Getty Images)

Will use Journavx as a brand name.

Get the fox work on the way by clicking here

Vertex CEO Reshma Kewalramani, “The first new class of pain in 20 years has been approved by the first new class of pain,” added as the company's “ability to change the Standard of Pain and create a new standard of care.”

Cleaning, according to his words, resulted in a “statistically important” reduction against a placebo in two days in two days. Court processes are random, double-blind, plasebo and active managed.

“Analyzeless therapeutic classes that are not a new opioid for acute pain provide the ability to reduce certain risks associated with an opioid use for pain and provide patients with other The choice of treatment“FDA Drug Assessment and Research Manager Dr. Jacqueline Curriger-Curriger-Curey Curey-Curey-Curay-Curey-Curey-Curey, the obligation to accelerate the development of this action and agency and confirming the operation of the agency and confirming the operation of the agency to the Opioids for Pain Management stressed. ”

A sign for food and medicine department outside the agency's headquarters, Maryland. (Sarah Silboiger / Getty Images / Getty Images)

Vertex said that almost 10% of patients use Opioids, Opioids to change Opioids Opute pain, opioids that can create a long time addictive.

Wegovy is approved by FDA for use for weight loss drugs, to use heart disease

According to the company, the cost of apples to Journavx will be $ 15.50.

The FDA said the leak was “contraindicated” for people who use the “strong CYP3A inhibitors”. Vertex is also advised not to take or drink anything that does not eat or grapefruit.

FDA after the announcement of Journavx's FDA approval, sent more than 5% of the price of Vertex shares, with shares and Friday. Meanwhile, market capitalization hovered around $ 119.81 billion in the afternoon.

Click here to read more in the fox work

The company also looked at the peripheral neuropathic pain applications for the drug.

Vertex has been in business since the late 1980s. According to the website, the company has FDA approval from six other drugs.